Cancer genomics: technology, discovery, and translation.
about
Genomic characterization of esophageal squamous cell carcinoma: Insights from next-generation sequencingLung cancer biomarkers, targeted therapies and clinical assaysPatterns of Chromosomal Aberrations in Solid TumorsCurrent and future molecular profiling of cancer by next-generation sequencingBioinformatics for precision medicine in oncology: principles and application to the SHIVA clinical trialFBXW7 mutations in patients with advanced cancers: clinical and molecular characteristics and outcomes with mTOR inhibitors.Sustained proliferation in cancer: Mechanisms and novel therapeutic targetsStrategies for modern biomarker and drug development in oncology.Network and data integration for biomarker signature discovery via network smoothed T-statistics.Communication of genetic test results to family and health-care providers following disclosure of research results.Genomic Analysis as the First Step toward Personalized Treatment in Renal Cell CarcinomaFeasibility of real time next generation sequencing of cancer genes linked to drug response: results from a clinical trial.Tumour heterogeneity in the clinic.Finding Fault? Exploring Legal Duties to Return Incidental Findings in Genomic Research.Use of four next-generation sequencing platforms to determine HIV-1 coreceptor tropism.Targeted sequencing of cancer-related genes in colorectal cancer using next-generation sequencingPulmonary squamous cell carcinoma and sorafenibLong insert whole genome sequencing for copy number variant and translocation detection.Following the crumbs: from tissue samples, to pharmacogenomics, to NSCLC therapyGenomic Characterization of Non-Small-Cell Lung Cancer in African Americans by Targeted Massively Parallel SequencingCan intensive longitudinal monitoring of individuals advance cancer research?Systematic assessment of multi-gene predictors of pan-cancer cell line sensitivity to drugs exploiting gene expression data.Data resources for the identification and interpretation of actionable mutations by clinicians.Personalized targeted therapy for lung cancerProfiling the immune stromal interface in breast cancer and its potential for clinical impactPIK3CA mutation H1047R is associated with response to PI3K/AKT/mTOR signaling pathway inhibitors in early-phase clinical trialsImpact of regular aspirin use on overall and cancer-specific survival in patients with colorectal cancer harboring a PIK3CA mutationIntroduction into PPPM as a new paradigm of public health service: an integrative view."Drivers" of translational cancer epidemiology in the 21st century: needs and opportunitiesNew targetable oncogenes in non-small-cell lung cancer.Awareness, Understanding, and Adoption of Precision Medicine to Deliver Personalized Treatment for Patients With Cancer: A Multinational Survey Comparison of Physicians and Patients.Plasmid-Based Materials as Multiplex Quality Controls and Calibrators for Clinical Next-Generation Sequencing Assays.Combining tumor genome simulation with crowdsourcing to benchmark somatic single-nucleotide-variant detection.Building a personalized medicine infrastructure at a major cancer center.Precision medicine for advanced prostate cancer.Application of next-generation sequencing in clinical oncology to advance personalized treatment of cancerMolecular Targeted Drugs and Biomarkers in NSCLC, the Evolving Role of Individualized TherapyDiagnostic assays for identification of anaplastic lymphoma kinase-positive non-small cell lung cancer.New strategies in personalized medicine for solid tumors: molecular markers and clinical trial designs.Molecular Subtyping of Pancreatic Cancer: Translating Genomics and Transcriptomics into the Clinic.
P2860
Q26768533-606C0956-AAA1-45A8-9413-741BDDE55FB2Q26775396-49AA7E31-85E3-4E2A-9D8A-7664938EBA77Q26786127-3ACA28FF-7386-424C-8CBC-7DCDCFDA4E7DQ26796272-16E71A41-E725-4D2B-8386-F4B839C1D1EDQ27015838-B740EA9C-C75A-4E77-9202-0096101CFFC3Q27852932-C50BA432-CFBF-4730-8BBC-9875315FDFD8Q28396388-0E4B03C2-D74F-454A-940B-572B84F0D0AEQ30590270-EA2A892A-76AA-4889-B68A-7D629FC2235FQ30665910-5F7FC16F-C4B9-4E2A-A898-577F3E20E380Q33563539-6E94CE41-F19D-483F-AA03-2EF7242C90EAQ33947929-45414F51-2AE6-496F-A548-00A410E53B3EQ34033475-C91CB57A-8E50-456F-889F-0920F8CF4996Q34372080-4DA37258-316A-4D91-900F-7E66A3D6E563Q34392460-B0BCBBC6-8B52-49D1-B6D2-4E913DDA999BQ34482589-7751124B-3E2B-4EF8-8A6A-7F37288452D0Q34735416-2A7BD330-8C4C-49AD-B00B-033932368FC4Q34998300-BD2C95F9-1603-4A7E-B95E-43F2EDA27B99Q35000323-94835D74-DD3B-421E-8B5E-9F00030597C1Q35200424-6B7E81EE-84AA-4C9B-8E4B-5F62886704A8Q35671373-2FF687B6-2417-4E63-89F5-9A9BFA0127B0Q35989936-14B9F837-1136-42A6-BD53-BF7C31C1858EQ36309864-5F6E4741-A87C-46CF-B95B-33E4433F1831Q36317783-DADC4742-F054-414A-B44E-19252B5D2952Q36321826-D4E6AF49-88F6-439E-8C80-59150B49FE5CQ36449295-3A9DD464-3FBF-451A-82BC-2D68BFF94A3CQ36510935-AFE3FC7C-F2CE-49AC-A394-F1C1557866EFQ36551145-A83D319C-5BCD-49CE-9623-F315620C1607Q36588428-082190B9-73EE-4ECE-9C37-EF59CCFE7F79Q36589104-C2218F12-89AF-42FB-96A1-4A4F877A8E78Q36660677-74914A91-0C3D-4E81-B849-9686F5F57C35Q36673460-726D5018-7278-414F-A342-F39A4053074DQ36853558-A0033F80-BC0C-4E4A-8E74-2C07B4F6B4ABQ36867676-3913079F-FB57-4A19-9D72-4D512DAD4854Q36929987-9A8856D5-F724-460A-ABFD-F4027DB47366Q37114034-B2EF8977-B735-4B9B-ACD4-9B0705015547Q37183603-2E44CC4D-5300-495F-A2C6-566E41DD3CECQ37347532-87EAA11E-56AD-410C-B101-CCA9627BC30BQ37604076-E1CDD651-BA98-4D90-A0A7-526865841F9AQ37724947-BE663FB1-74CE-4355-BA63-3DF127D6F031Q37726365-B5C38417-18CE-4916-B9BC-E3C8ACC33246
P2860
Cancer genomics: technology, discovery, and translation.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Cancer genomics: technology, discovery, and translation.
@en
Cancer genomics: technology, discovery, and translation.
@nl
type
label
Cancer genomics: technology, discovery, and translation.
@en
Cancer genomics: technology, discovery, and translation.
@nl
prefLabel
Cancer genomics: technology, discovery, and translation.
@en
Cancer genomics: technology, discovery, and translation.
@nl
P2093
P50
P356
P1476
Cancer genomics: technology, discovery, and translation.
@en
P2093
Andrew M K Brown
Benjamin G Neel
Janet E Dancey
Lillian L Siu
Nicole Onetto
Patricia Shaw
Thomas J Hudson
Tong Zhang
P304
P356
10.1200/JCO.2011.39.2316
P407
P577
2012-01-23T00:00:00Z